Results from the First Global NET Survey – Part 1: Time to Diagnosis
Patients with neuroendocrine tumors (NET) often remain undiagnosed for years due to vague signs or symptoms, or even a lack of symptoms. Learn more about the NET diagnostic process from key highlights of the Global NET Survey.
Learn more: NETCancerExperience.com
© 2016 Novartis AG
